PatientsVille.com Logo

MALIGNANT NEOPLASM PROGRESSION and Clonazepam

PatientsVille

MALIGNANT NEOPLASM PROGRESSION Symptoms and Causes

Lung cancer is one of the most common cancers in the world. It is a leading cause of cancer death in men and women in the United States. Cigarette smoking causes most lung cancers. The more cigarettes you smoke per day and the earlier you started smoking, the greater your risk of lung cancer. High levels of pollution, radiation and asbestos exposure may also increase risk.

Common symptoms of lung cancer include

  • A cough that doesn't go away and gets worse over time
  • Constant chest pain
  • Coughing up blood
  • Shortness of breath, wheezing, or hoarseness
  • Repeated problems with pneumonia or bronchitis
  • Swelling of the neck and face
  • Loss of appetite or weight loss
  • Fatigue

Doctors diagnose lung cancer using a physical exam, imaging, and lab tests. Treatment depends on the type, stage, and how advanced it is. Treatments include surgery, chemotherapy, radiation therapy, and targeted therapy. Targeted therapy uses substances that attack cancer cells without harming normal cells.

NIH: National Cancer Institute

Check out the latest treatments for MALIGNANT NEOPLASM PROGRESSION

MALIGNANT NEOPLASM PROGRESSION treatment research studies

Clonazepam clinical trials, surveys and public health registries


Find Drug Side Effect reports



Clonazepam Side Effects

Completed Suicide (405)
Death (302)
Toxicity To Various Agents (290)
Cardiac Arrest (268)
Respiratory Arrest (250)
Cardio-respiratory Arrest (145)
Anxiety (141)
Dizziness (112)
Overdose (108)
Headache (93)
Somnolence (91)
Convulsion (83)
Poisoning (81)
Depression (75)
Nausea (75)
Confusional State (73)
Fatigue (70)
Agitation (69)
Insomnia (67)
Pain (64)
Dyspnoea (59)
Product Substitution Issue (58)
Tremor (57)
Asthenia (53)
Condition Aggravated (53)
Fall (52)
Diarrhoea (52)
Suicidal Ideation (51)
Suicide Attempt (50)
Feeling Abnormal (50)
Vomiting (47)
Loss Of Consciousness (46)
Intentional Overdose (46)
Malaise (44)
Abdominal Pain Upper (44)
Pyrexia (42)
Amnesia (41)
Chest Pain (39)
Hypotension (37)
Weight Increased (36)
Balance Disorder (36)
Gait Disturbance (35)
Abdominal Pain (35)
Tachycardia (35)
Weight Decreased (33)
Sedation (33)
Pain In Extremity (33)
Abnormal Behaviour (33)
Irritability (32)
Rash (32)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

MALIGNANT NEOPLASM PROGRESSION Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus
Conditions: Status Epilepticus;   Epilepsy
Interventions: Drug: Clonazepam;   Drug: Fosphenytoin;   Drug: Placebo;   Drug: Lorazepam
Outcome Measures: Percentage of patient with a cessation of seizures and absence of recurrence;   Duration between the first cessation and the recurrence of seizures;   Percentage of patients having had a second injection of benzodiazepine;   Percentage of patients having had an injection of the second line treatment;   Percentage of patients having a general anesthesia for refractory status epilepticus;   Percentage of patients having had a side effect;   Percentage of patients having been mechanically ventilated;   Glasgow Coma Scale;   Mortality;   Length of stay in Intensive Care Unit;   Length of stay in hospital
2 Not yet recruiting Clobazam Use in Epilepsia Partialis Continua - Pilot Study
Conditions: Epilepsia Partialis Continua;   Kojewnikov's Epilepsy;   Epilepsy
Interventions: Drug: Clobazam;   Drug: Clonazepam;   Drug: Lorazepam
Outcome Measures: Time (measured in minutes) to onset of seizure freedom;   Reduction of seizure frequency/minute;   Mental status preservation off sedating anticonvulsants as measured by the MoCA© scale;   Ambulatory function as measured by the Hauser Ambulation Index
3 Recruiting Gabapentin Treatment of Benzodiazepine Dependence
Condition: Benzodiazepine Dependence
Interventions: Drug: gabapentin;   Drug: Placebo
Outcome Measure: Abstinence from Benzodiazepine use
4 Unknown  Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus
Condition: Status Epilepticus
Intervention: Drug: levetiracetam (add-on)
Outcome Measures: o Uneventful intravenous (iv) administration of study medication;   o Toxicity profile on iv administration, including:;   § Irritation on injection site;   § Hypotension, defined as systolic blood pressure below 90 mm Hg recorded within 24 hours of the dose;   § Cardiac arrest (diagnosed clinically) or bradyarrhythmias including heart block, documented on an electrocardiogram;   § Respiratory depression, defined as the occurrence of apnea or need for intubation;   § Allergic reactions, like skin rash;   § Other side-effects;   Pharmacokinetic parameters of levetiracetam and Clonazepam in patients with SE
5 Unknown  The Efficacy of Botulinum Toxin in Disabling Multiple Sclerosis (MS) Tremor
Conditions: Multiple Sclerosis;   Tremor
Intervention: Drug: Botulinum Toxin Type A
Outcome Measures: A decrease in tremor;   The safety profile of Botulinum Toxin in MS patients